Toxic epidermal necrolyis after vancomycin use: a case report and discussion of management.

Autor: Changela A; Department of Internal Medicine, The Brooklyn Hospital Center, Brooklyn, NY 11201, USA. aachange@gmail.com, Javaiya H, Rickenback K, Elnawawi A, Changela K
Jazyk: angličtina
Zdroj: American journal of therapeutics [Am J Ther] 2013 Mar-Apr; Vol. 20 (2), pp. 223-5.
DOI: 10.1097/MJT.0b013e3181f94c27
Abstrakt: Vancomycin is a commonly used antibiotic for severe Gram-positive bacterial infections, especially for methicillin-resistant Staphylococcus Aureus and coagulase-negative staphylococci infections. Nevertheless, only few cases of toxic epidermal necrolysis have been reported since the introduction of Vancomycin into clinical practice. We report a case of a 35-year-old man who presented with multiple facial abscesses and methicillin-resistant Staphylococcus Aureus bactermia and who was started on Vancomycin and later developed toxic epidermal necrolysis.
Databáze: MEDLINE